Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
ConditionLung Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorAstraZeneca
About this trial
A prospective, longitudinal, single-arm interventional study of lung cancer screening.
Eligibility criteria
Qualifiers
Age between ≥50 and ≤80 years.
Be a current smoker or have quit 15 years ago or less.
Have participated or are currently participating in smoking cessation program.
Lifetime smoking exposure equal to or greater than 20 pack-year.
Disqualifiers
Contraindications to the screening examination: (claustrophobic or weighing more than 130 kgs).
Inability to climb 3 stair steps non-stop (36 steps).
Disabling dyspnea
pleuritic chest pain
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Research Site20230-130, Rio de Janeiro Brazil
Sponsors and collaborators
AstraZeneca
Lead sponsor
Source ClinicalTrials.gov